首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1544655

紅斑治療市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Rosacea Treatment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月10日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於紅斑性痤瘡盛行率上升，2024 年至 2032 年間，紅斑性痤瘡治療市場規模預計將達到 6.5% 的複合年成長率。隨著人們對紅斑痤瘡認知的提高，越來越多的人尋求診斷和治療，從而增加了對有效療法的需求。皮膚病學研究的進步已經為創新療法開闢了道路，包括外用和口服藥物、雷射療法和先進的護膚產品，所有這些都針對紅斑痤瘡的不同症狀。

對紅斑痤瘡病因和觸發因素的深入研究也催生了量身定做的治療方法，以滿足患者的個別需求。非處方治療的激增以及新的非處方產品可以解決輕度至中度紅斑痤瘡病例，從而拓寬了傳統處方療法以外的市場。

整個產業分為類型、治療類型、藥品類別、配銷通路和區域。

根據類型，由於人們越來越認知到紅斑痤瘡對眼睛健康的影響以及對專業治療的需求，預計到 2032 年，眼紅斑痤瘡細分市場的紅斑痤瘡治療市場規模將出現前所未有的成長。眼部紅斑痤瘡的不適也需要有針對性的治療。這種認知加強了對開發與眼睛相關的紅斑痤瘡症狀的治療方法的關注。

就配銷通路而言，預計到 2032 年，線上藥局領域的紅斑痤瘡治療市場將錄得顯著成長。網路藥局還為患者提供各種紅斑痤瘡治療方法，包括處方藥、非處方產品和專門的護膚方案，所有這些都可以輕鬆送貨上門。

由於城市化、對皮膚病問題認知的提高以及先進護膚解決方案的採用，到 2032 年，亞太地區紅斑痤瘡治療行業規模將大幅成長。隨著皮膚病學健康日益受到重視，對有效紅斑痤瘡治療的需求激增。在不斷擴大的醫療基礎設施和針對不同皮膚類型的創新治療的支持下，該區域市場將呈現上升趨勢。

產業生態系統分析
產業影響力
- 成長動力
  - 紅斑痤瘡盛行率增加
  - 聯合療法和藥物的進展
  - 提高認知和診斷
  - 改善診斷和治療的機會
- 產業陷阱與挑戰
  - 高治療成本和替代治療方案的可用性
成長潛力分析
監管環境
技術景觀
管道分析
波特的分析
PESTEL分析
未來市場趨勢
差距分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
紅斑毛細血管擴張性酒渣鼻
丘疹膿皰性酒糟鼻
眼部紅斑痤瘡
植物性紅斑痤瘡

第 6 章：市場估計與預測：按治療類型，2021 - 2032 年

主要趨勢
口服
專題
其他治療類型

第 7 章：市場估計與預測：按藥物類別，2021 - 2032 年

主要趨勢
抗生素
α激動劑
類維生素A
皮質類固醇
免疫抑制劑
其他藥物類別

第 8 章：市場估計與預測：按配銷通路分類，2021 - 2032 年

主要趨勢
醫院藥房
零售藥局
網路藥局

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Aclaris Therapeutics
Colorescience, Inc.
Croda International Plc
Dr. Reddy's Laboratories Ltd
Galderma
Journey Medical Corporation
Leopharma
Lupin
Maruho Co.,Ltd.
Merck and Co., Inc
Mylan N.V.
Perrigo Company plc
PRUGEN
Sol-Gel Technologies Ltd

簡介目錄

Product Code: 10190

Rosacea treatment market size is poised to witness a 6.5% CAGR between 2024 and 2032 driven by the rising prevalence of rosacea. As awareness of rosacea increases, more individuals are seeking diagnoses and treatments, boosting the demand for effective therapies. Dermatological research advancements have made way for innovative treatments, spanning topical and oral medications, laser therapies, and advanced skincare products, all targeting diverse symptoms of rosacea.

Heightened research into the causes and triggers of rosacea has also birthed tailored treatments, that cater to individual patient needs. The surge in over-the-counter treatments, alongside new non-prescription products, addresses mild to moderate rosacea cases, broadening the market beyond traditional prescription therapies.

The overall industry is divided into type, treatment type, drug class, distribution channel, and region.

Based on type, the rosacea treatment market size from the ocular rosacea segment is anticipated to witness unprecedented growth through 2032 driven by the heightened awareness of its impact on eye health and the demand for specialized treatments. The discomfort of ocular rosacea also necessitates targeted therapies. This awareness has intensified the focus on developing treatments for eye-related rosacea symptoms.

With respect to distribution channel, the rosacea treatment market from the online pharmacies segment is predicted to record notable gains up to 2032. This is owing to the increased convenience and accessibility these settings offer for purchasing medications and skincare products. Online pharmacies also provide patients with a wide range of rosacea treatments, including prescription medications, over-the-counter products, and specialized skincare regimens, all available with the ease of home delivery.

Asia Pacific rosacea treatment industry size will grow significantly through 2032 attributed to urbanization, heightened awareness of dermatological issues, and the adoption of advanced skincare solutions. As dermatological health gains prominence, the demand for effective rosacea treatments surges. Bolstered by an expanding healthcare infrastructure and innovative treatments tailored to diverse skin types, the regional market will witness an upward trajectory.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of rosacea
  - 3.2.1.2 Advancements in combination therapies and drugs
  - 3.2.1.3 Rising awareness and diagnosis
  - 3.2.1.4 Improving access to diagnosis and treatment
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High treatment costs and availability of alternative treatment options
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Pipeline analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Erythematotelangiectatic rosacea
5.3 Papulopustular rosacea
5.4 Ocular rosacea
5.5 Phymatous rosacea

Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Oral
6.3 Topical
6.4 Other treatment types

Chapter 7 Market Estimates and Forecast, By Drug Class, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Antibiotic
7.3 Alpha agonist
7.4 Retinoid
7.5 Corticosteroid
7.6 Immunosuppressant
7.7 Other drug classes

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Online pharmacies

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa